Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Balance Sheets

v3.19.3.a.u2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 49,724 $ 83,103
Other current assets 2,409 1,471
Total current assets 52,133 84,574
Investment in Charter, accounted for using the equity method (note 5) 12,194,674 12,004,376
Other assets 9,535 9,487
Total assets 12,256,342 12,098,437
Current liabilities:    
Accounts payable and accrued liabilities 6,168 3,504
Deferred revenue and other current liabilities 5,971 4,691
Total current liabilities 12,139 8,195
Debt (note 6) 572,944 522,928
Deferred income tax liabilities (note 7) 999,757 965,829
Other liabilities 3,556 2,867
Total liabilities 1,588,396 1,499,819
Equity    
Preferred stock, $.01 par value. Authorized 50,000,000 shares; no shares issued
Additional paid-in capital 7,890,084 7,938,357
Accumulated other comprehensive earnings, net of taxes 8,158 7,778
Retained earnings (accumulated deficit) 2,767,885 2,650,669
Total equity 10,667,946 10,598,618
Commitments and contingencies (note 11)
Total liabilities and equity 12,256,342 12,098,437
Series A common stock    
Equity    
Common stock 265 263
Series B common stock    
Equity    
Common stock 25 25
Series C common stock    
Equity    
Common stock $ 1,529 $ 1,526